Pharmaceutical production depends on validated systems remaining controlled throughout their lifecycle. AMDT protects the configurations behind critical automation with automated backup, version control, documented change history, and recovery - creating trusted operational records that support data integrity, validation, audit readiness, and production resilience.
Know what is running. Know what changed.
Preserve the validated state.
| The stake | The exposure | AMDT's answer | |
|---|---|---|---|
|
Validated state | Changes to automation configurations can affect a validated production environment and trigger investigation, documentation, testing, or revalidation activities. | Controlled versions, configuration comparison, and complete histories provide evidence of what changed and establish a trusted record of operational states. |
|
|
Data integrity & traceability | Fragmented files, undocumented modifications, and manual records make it harder to demonstrate how critical systems changed over time. | Centralized version histories, attributable change records, timestamps, and controlled backups strengthen operational traceability and data integrity. |
|
|
Production continuity | Drug shortages and compliance findings are public - regulator trust, once lost, reprices everything | A failed controller, configuration error, or cyber incident can stop a validated process. Recovery uncertainty can extend downtime and complicate the path back to production. |
|
|
Regulatory readiness | FDA, GMP, EU Annex 11, and other regulated environments require disciplined control of computerized systems, records, changes, security, and lifecycle processes. | Backup evidence, version histories, change records, asset information, and reporting support the operational controls and documentation behind regulated manufacturing. |
| In pharmaceutical production, control and evidence are inseparable: knowing the operational state is important; being able to demonstrate how it changed and how it is protected is equally critical. | |||
Audit readiness shouldn’t begin when an inspection is scheduled. The records needed to understand system configurations, versions, backups, and changes should be created continuously as part of normal operations.
Octoplant maintains controlled configuration histories across supported automation systems, helping engineering and validation teams answer fundamental questions without reconstructing the past from spreadsheets, project folders, or individual memory.
What was running? What changed? When did it change? What existed before? Is a trusted backup available?
The evidence is created when the work happens – not when someone asks to see it.
A pharmaceutical process may be validated, but the automation underneath it doesn’t stand still. PLC programs change. HMI projects are updated. Drives and controllers are replaced. OEMs service equipment. Software and firmware evolve. Cybersecurity teams respond to vulnerabilities.
Every intervention can create a new operational state.
Octoplant provides a controlled history across supported PLCs, HMIs, SCADA and DCS systems, robots, drives, and other industrial technologies. Configurations are backed up, versions are maintained, and differences can be compared — helping teams understand whether the production environment still reflects the state they expect.
Validation establishes the state. Version control helps you protect its history.
Pharmaceutical data integrity isn’t limited to laboratory or business systems. The automation controlling production also creates and depends on electronic information — programs, configurations, parameters, versions, and change histories that describe how equipment operates.
Maintaining a controlled history of that information helps engineering, quality, and validation teams understand the operational state of production systems over time.
Octoplant centralizes configuration versions and change history, reducing dependence on uncontrolled copies, local folders, engineering laptops, and individual knowledge.
Change is unavoidable in pharmaceutical production. Equipment is maintained, processes improve, components become obsolete, software is updated, and vulnerabilities require remediation.
What matters is whether the organization can understand and document that change.
Device-aware comparison and version history help engineering teams identify configuration differences and maintain a chronological operational record. That information can support change assessment, troubleshooting, deviation investigation, validation activities, and audit preparation.
Change without history creates uncertainty. Controlled change creates evidence.
| Production environment | What matters | How AMDT helps | |
|---|---|---|---|
|
|
API & process manufacturing | Complex process automation, batch systems, control parameters, and long equipment lifecycles require disciplined configuration management. | Maintain controlled backups, historical versions, and configuration comparisons across supported automation systems. |
|
|
Drug product manufacturing | Validated production equipment must remain controlled as maintenance, engineering, and process changes occur. | Preserve configuration history and provide evidence of how operational states change over time. |
|
|
Fill & finish | Highly automated filling, inspection, handling, and packaging processes combine precision with high downtime sensitivity. | Protect critical automation configurations and maintain trusted historical states for troubleshooting and recovery. |
|
|
Packaging & serialization | Packaging, labeling, inspection, and serialization environments change frequently across products, formats, and markets. | Track configuration changes and maintain controlled versions across the automation behind end-of-line operations. |
| Pharmaceutical production environments vary significantly, but they share a common requirement: automation systems must remain controlled, traceable, recoverable, and supported by trustworthy operational records. | |||
Pharmaceutical manufacturers operate within overlapping quality, data-integrity, cybersecurity, and computerized-system requirements. The specific obligations differ by jurisdiction and application, but the underlying operational disciplines are closely related: controlled systems, trustworthy records, documented changes, security, lifecycle management, and recoverability.
FDA 21 CFR Part 11
Electronic records and electronic signatures where Part 11 applies alongside FDA predicate-rule requirements.
FDA cGMP / 21 CFR Part 210 & 211
Manufacturing controls, records, quality systems, and production requirements for drug manufacturing.
EU GMP Annex 11
Computerized systems used in GMP activities, including validation, data integrity, change/configuration management, security, and lifecycle controls.
GAMP 5
Risk-based good practice for compliant GxP computerized systems throughout their lifecycle.
NIS2 / cybersecurity requirements
Cyber risk management and resilience requirements where pharmaceutical organizations fall within applicable scope.
